南米および中米のオピオイド市場予測 2030年 - 地域別分析 - 製品別（即効性短時間作用型オピオイドおよび徐放性長時間作用型オピオイド）、用途別（疼痛管理、麻酔、下痢抑制、咳抑制、依存症治療など）、投与経路別（経口、注射、経皮パッチ）、流通チャネル別（病院薬局および小売薬局）
高齢者人口の増加が南米および中米のオピオイド市場を活性化
高齢者の大多数は慢性的な痛みを抱えて生活しており、その結果、日常生活を遂行する体力が低下しています。高齢者人口は、骨や関節の障害、関節炎、がん、その他の痛みを引き起こす慢性疾患に広く苦しんでいます。2018年2月の世界保健機関（WHO）のデータによると、高齢者人口は2015年の12％と比較して、2050年までに22％増加すると推定されています。データはまた、低所得国と中所得国がこの急増のほぼ80％を占めると述べています。多くの先進国でも、医療施設の改善と医療サービスの向上により、高齢者人口が大幅に増加しています。その結果、これらの地域では平均寿命が延びています。人口の高齢化は、主に疼痛管理ソリューションの需要増加を通じてオピオイド市場を牽引しています。さらに、高齢者は疼痛管理を必要とする手術や医療処置を受けることがよくあります。したがって、地域全体で高齢者人口が増加していることが、オピオイド市場の成長を牽引しています。
南米および中米のオピオイド市場の概要
汎米保健機構 (PAHO) のデータによると、ブラジルでは 3,000 万人以上が 60 歳以上で、同国の人口の 13% を占めています。2030 年までに、この数は約 5,000 万人に達し、ブラジルの人口の 24% を占めると予想されています。ブラジル地理統計研究所によると、2050年までに65歳以上の人口がブラジルの総人口の36％を占めると予想されています。慢性疼痛は高齢者に最もよく見られる症状の1つです。この症状に苦しむ人々はオピオイド製品の使用を好み、オピオイド処方の増加につながっています。
ブラジル保健監督庁（ANVISA）とブラジルの民間病院システムによると、ブラジルはCOVID-19パンデミックの発生により深刻な影響を受け、2022年4月の時点で70万人が死亡しています。ブラジル保健監督庁（ANVISA）とブラジルの民間病院システムによると、ワクチンの入手が遅れたために国民の健康状態が悪化し、重症例では入院と人工呼吸器の使用率が高くなり、挿管中に鎮静剤として使用されるフェンタニルの需要が加速しました。
さらに、2023年4月にThe Lancet Regional Health-Americasに発表されたデータによると、過去20年間でブラジルでは医療目的と非医療目的を含めて処方オピオイドの使用が増加しており、これがブラジルの市場を牽引しています。
南米および中米のオピオイド市場の収益と2030年までの予測（百万米ドル）
南米および中米のオピオイド市場のセグメンテーション
南米および中米のオピオイド市場は、製品、用途、投与経路、流通チャネル、および国に分類されています。
製品に基づいて、南米および中米のオピオイド市場は、即放性短時間作用型オピオイドと徐放性長時間作用型オピオイドに分割されています。即放性短時間作用型オピオイドセグメントは、2022年に大きな市場シェアを占めました。即放性短時間作用型オピオイドは、オキシコドン、ヒドロコドン、トラマドール、コジン、プロポキシフェンなどにさらに細分化されています。徐放性長時間作用型オピオイドは、オキシコドン、フェンタニル、モルヒネ、メタドンなどにさらに細分化されています。
用途別に見ると、南米および中米のオピオイド市場は、疼痛管理、麻酔、下痢抑制、咳抑制、依存症治療などに分類されています。疼痛管理セグメントは、2022年に最大の市場シェアを占めました。
投与経路別に見ると、南米および中米のオピオイド市場は、経口、注射、経皮パッチに分類されています。 2022年には経口セグメントが最大の市場シェアを占めました。
流通チャネル別に見ると、南米および中米のオピオイド市場は病院薬局と小売薬局に分かれています。病院薬局セグメントは2022年に大きな市場シェアを占めました。
国別に見ると、南米および中米のオピオイド市場はブラジル、アルゼンチン、その他のラテンアメリカ諸国に分かれています。2022年にはブラジルが南米および中米のオピオイド市場シェアを独占しました。
Endo International plc、Mallinckrodt Plc、Neuraxpharm Pharmaceuticals SL、Rusan Pharma Ltd、Teva Pharmaceutical Industries Ltdは、南米および中米のオピオイド市場で事業を展開している大手企業の一部です。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - South & Central America Analysis
5.1 South & Central America Opioids Market Revenue (US$ Million), 2020-2030
5.2 South & Central America Opioids Market Forecast Analysis
6. South & Central America Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. South & Central America Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Opioids Market - Country Analysis
10.1 South & Central America
10.1.1 South & Central America Opioids Market, by Key Countries - Revenue (2022) (US$ Million)
10.1.2 South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.2.1 South & Central America: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.2.2 Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Brazil: South & Central America Opioids Market Breakdown, by Product
10.1.2.2.2 Brazil: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.2.3 Brazil: South & Central America Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.2.2.4 Brazil: South & Central America Opioids Market Breakdown, by Application
10.1.2.2.5 Brazil: South & Central America Opioids Market Breakdown, by Route of Administration
10.1.2.2.6 Brazil: South & Central America Opioids Market Breakdown, by Distribution Channel
10.1.2.3 Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Argentina: South & Central America Opioids Market Breakdown, by Product
10.1.2.3.2 Argentina: South & Central America Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.3.3 Argentina: South & Central America Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.2.3.4 Argentina: South & Central America Opioids Market Breakdown, by Application
10.1.2.3.5 Argentina: South & Central America Opioids Market Breakdown, by Route of Administration
10.1.2.3.6 Argentina: South & Central America Opioids Market Breakdown, by Distribution Channel
10.1.2.4 Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Rest of South & Central America: Opioids Market Breakdown, by Product
10.1.2.4.2 Rest of South & Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.2.4.3 Rest of South & Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
10.1.2.4.4 Rest of South & Central America: Opioids Market Breakdown, by Application
10.1.2.4.5 Rest of South & Central America: Opioids Market Breakdown, by Route of Administration
10.1.2.4.6 Rest of South & Central America: Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Rusan Pharma Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. South & Central America Opioids Market Segmentation
Table 2. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 13. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long Acting Opioid
Table 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. Recent Organic Growth Strategies in Opioids Market
Table 29. Recent Inorganic Growth Strategies in the Opioids Market
Table 30. Glossary of Terms, Opioids Market
List of Figures
Figure 1. South & Central America Opioids Market Segmentation, by Country
Figure 2. South & Central America Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. South & Central America Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. South & Central America Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. South & Central America Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. South & Central America Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. South & Central America: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 23. Brazil: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Argentina: South & Central America Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Rest of South & Central America: Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Growth Strategies in Opioids Market
- Endo International plc
- Mallinckrodt Plc
- Neuraxpharm Pharmaceuticals SL
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America opioids market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America opioids market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.